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Mice homozygous for the autosomal recessive mutation claw paw (clp) are characterized by limb posture abnormalities and congenital
hypomyelination, with delayed onset of myelination of the peripheral nervous system but not the central nervous system. Although this
combination of limb and peripheral nerve abnormalities in clp/clp mice might suggest a common neurogenic origin of the syndrome, it is not
clear whether the clp gene acts primarily in the neurone, the Schwann cell or both. In the work described here, we address this question of cell
autonomy of the clp mutation through reciprocal nerve grafting experiments between wild-type and clp/clp animals. Our results demonstrate
that the clp mutation affects the Schwann cell compartment and possibly also the neuronal compartment. These data suggest that the clp gene
product is expressed in Schwann cells as well as neurones and is likely to be involved in direct axon–Schwann cell interactions. Within the
Schwann cell, clp affects a myelin-related signaling pathway that regulates periaxin and Krox-20 expression, but not Oct-6.
D 2004 Elsevier Inc. All rights reserved.Keywords: Myelination; Schwann cell; Arthrogryposis; POU factors; PeriaxinIntroduction
Congenital limb posture abnormalities in humans and
other vertebrates occur under a variety of circumstances and
clinically manifest as a singular abnormality or as part of a
syndrome. In clinical practice, such abnormalities are de-
scribed as arthrogryposis multiplex congenita (AMC;
arthron = ‘‘joint’’ and gryposis = ‘‘bent’’). It is generally
accepted that any condition resulting in reduced fetal
movement will lead to joint contractures in newborns
(Drachman, 1971; Hageman and Willemse, 1983; Hall,
1997). In principle, such conditions could be extrinsic or
intrinsic to the developing fetus. An example of the former
is provided by experiments in which chick or rat embryos
were paralyzed by injection with curare, causing limb
posture abnormalities at birth (Del Torto et al., 1983;
Drachman and Coulombre, 1962; Moessinger, 1983). Ad-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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fetal acetylcholine receptor cause arthrogryposis in human
fetuses (Jacobson et al., 1999; Matthews et al., 2002; Polizzi
et al., 2000).
Intrinsic causes of reduced fetal movement can be classi-
fied as either myogenic and/or neurogenic in origin. In
several clinical cases, AMC was found associated with
congenital hypomyelination of the peripheral nerves suggest-
ing a common aetiology (Boylan et al., 1992; Charnas et al.,
1988; Seitz et al., 1986). In the peripheral nervous system,
myelin formation and maintenance of the peripheral nervous
system by Schwann cells is dependent on continuous recip-
rocal interactions between the axon and Schwann cell (Fields
and Stevens-Graham, 2002). Mutations that affect this dia-
logue by disabling function in the Schwann cell, the axon or
in both result in dys- or demyelinating neuropathies as in the
human hereditary motor and sensory neuropathies (Suter and
Scherer, 2003). Limb posture abnormalities, mostly pes
cavus, and distal muscle wasting frequently develop in these
patients as consequence of axonal loss.
Congenital limb posture abnormalities are observed in
mice homozygous for the murine autosomal recessive
mutation claw paw (clp) (Henry et al., 1991). In affected
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(shoulder, wrist or digital joints) but extended at the elbow,
resulting in the forelimbs pointing in the direction of the
hindlimbs. These abnormalities are visible within 2 days of
birth. More severely affected animals also show involve-
ment of one or both hindlimbs. Pathological examination of
affected animals demonstrates severe congenital hypomye-
lination with delayed onset of myelination of the peripheral
nerves with central nerves unaffected. Persistently blocked
myelination is observed in a fraction of the smaller axons
(Henry et al., 1991). Additionally, it was found that the
mean internodal length is greatly reduced for all axonal size
classes in clp/clp nerves when compared to heterozygous or
wild-type animals (Koszowski et al., 1998). The clp gene
has not been identified yet, although mapping studies have
placed the gene close to the Gpi locus on mouse chromo-
some 7 (Henry et al., 1991). No mutations were found in the
myelin-associated glycoprotein (MAG) gene, close to the
Gpi locus, excluding this gene as a clp candidate (Niemann
et al., 1998). The pathology of the clp/clp mouse is
strikingly similar to the clinically described cases of AMC
mentioned above. Hence, clp/clp mice provide an opportu-
nity to study the basis of the relationship between arthrog-
ryposis and hypomyelination.
It has been hypothesized that the clp gene is part of the
neurone–glia signaling system that governs myelination
initiation during development. However, it is not known
what cellular and molecular components of this signaling
system are affected by the clp mutation. To further charac-
terize this mutant mouse, we set out to determine whether
the gene acts in the neurone, the Schwann cell or both,
through reciprocal nerve graft experiments. Additionally, we
studied the interaction of the clp gene with many known
Schwann cell autonomous regulatory genes involved in
myelination including the transcription factors Oct-6 and
Krox-20 (Topilko and Meijer, 2001). Our results indicate
that clp function is required within the Schwann cell as well
as in the neurone. Upregulation of the promyelin transcrip-
tion factor Oct-6 is not affected by clp, while the subsequent
Krox-20 activation is delayed. Additionally, embryonic
periaxin expression is absent or reduced in clp/clp Schwann
cells and postnatal expression is delayed. Taken together,
these results suggest that clp is involved in neurone–glia
interactions and furthermore that, within the Schwann cell,
clp is involved in a pathway that regulates periaxin and
Krox-20 expression. This clp-dependent pathway is parallel
and non-redundant to the myelin-related Oct-6-dependent
pathway.Materials and methods
Animal surgery
Nerve crush experiments were performed on young adult
F2 animals from a C57BL6J/Balbc-clp heterozygous inter-cross. Affected and non-affected mice were anesthetized by
inhalation of halothane and placed on a heating pad. The left
sciatic nerve was exposed and crushed for two times 15 s at
mid-femoral level using No.5 Biology forceps. Mice were
sacrificed 4 weeks after the operation through trans-cardiac
perfusion with a solution of 1% gluteraldehyde/3% parafor-
maldehyde in 100 mM cacodylate (pH 7.4). The operated
and contralateral nerve was isolated for light and electron
microscopic analysis.
Transplantation experiment
Reciprocal nerve grafting experiments were performed
between wild type and wild type (wt:wt), wild type and
clp/clp (wt:clp), clp/clp and wild type (clp:wt) and between
clp/clp and clp/clp (clp:clp). All animals were of C57BL6J
background, obviating the use of immune-suppressants to
prevent graft rejection. Operations were performed on two
animals at a time, both animals serving as nerve donor and
recipient. Two mice of appropriate genotype were anesthe-
tized through inhalation of halothane and placed on a
heating pad. The left sciatic nerve was exposed in both
animals. Approximately 7.5 –10 mm of nerve was excised
and placed in the same orientation in the host animal. Nerve
and muscle tissue were kept wet by regular application of a
drop of sterile phosphate-buffered saline (PBS). The nerves
were sutured at both the proximal and distal anastomosis site
with two 10-0 black filament sutures. The retracted muscles
were placed back in position and the skin was sutured. All
surgical manipulations were done under a microscope.
Animals were transferred to a clean cage and allowed to
recover under a heating lamp. Animals were carefully
monitored for wound healing on a daily basis. Four weeks
after transplantation, animals were sacrificed.
Perineurium permeability
A 1% Evans Blue (Sigma) solution in 5% bovine serum
albumin (fraction V)/PBS (pH 7.4) was dialyzed overnight
in PBS. The sciatic nerves of an adult claw paw animal and
a wild-type littermate were dissected out and placed imme-
diately in 4 ml of Evans blue albumin (EBA) solution at
room temperature. After a 30- or 60-min incubation period,
nerves were briefly washed in PBS and fixed in 4%
paraformaldehyde for 2 h. Nerves were cryoprotected in
30% sucrose/PBS, frozen and sectioned at 24 Am. Sections
were mounted in VectashieldR (Vector laboratories) and
viewed immediately under a fluorescence microscope.
Quantitative RT-PCR
Total RNAwas extracted from sciatic nerves using RNA-
Bee (Tel Test Inc.). First-strand cDNA was generated using
Superscript II (Invitrogen) reverse transcriptase and oligo-
dT as primer. The following primers were used to amplify
dhh and cyclophilin transcripts: dhh forward, CATGTGGC-
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GCCAGTA; cyclophilin forward, GGTCAACCCCAC-
CGTGTTCTTCGACAT; cyclophilin reverse, GGACAA-
GATGCCAGGACCTGTATGCT. Annealing temperature
for dhh primers: 60jC, annealing temperature for cyclo-
philin primers 68jC. Aliquots were taken from the reaction
with two cycle intervals and amplification products were
analyzed on a 1.8% agarose gel.
Light/electron microscopy
Anesthetized animals were sacrificed through transcar-
dial perfusion with PBS (pH 7.4) for 3 min followed by
fixative [3% PFA (Sigma); 1% glutaraldehyde (Sigma) in
100 mM cacodylate buffer, pH 7.2] for 10 min. Sciatic
nerves were isolated, fixed overnight in the same fixative at
4jC. The next day, nerves were rinsed with 0.2 M cacody-
late buffer, osmicated in 1% osmium tetroxide solution and
embedded in Epon. Sections (1 Am) of Epon-embedded
sciatic nerves were mounted on glass slides and stained with
methylene blue. Ultra-thin cross sections from nerve grafts
at mid-graft level were cut and uranyl acetate and lead
citrate stained for electron microscopic analysis (Philips
CM100).
Nerve conduction velocities
Nerve conduction velocities were measured on the tail
nerve of anesthetized animals. Animals were placed on a
thermo-comfort heating pad at 38jC. Recording and stim-
ulation electrodes were made of 300-Am tungsten needles
with a 10-Am tip. The stimulus frequency and stimulation
period was 1 Hz and 0.1 ms, respectively. Impedance of the
recording electrode was 100 and 25 kV/kHz for the stim-
ulation electrode.
Immunohistochemistry
Rabbit polyclonal antibodies used in this study are direct-
ed against Oct-6 (Jaegle et al., 2003), Periaxin (Scherer et al.,
1995) andKrox-20 (1:400). The Krox-20 antibodywas raised
against the unique amino-terminal portion of the protein
(amino acids 1–180). Animals were immunized with
6xHis-tagged Krox-201–180 protein expressed in E. coli
(M15 strain) and purified on Ni2+-NTA-agarose beads (QIA-
GEN). Mouse monoclonal antibodies used were against P-
zero (1:1000) (Archelos et al., 1993) and neurofilament
medium chain (1:200, hybridoma 2H3, Developmental Stud-
ies Hybridoma Bank).
Embryos and tissues were isolated, fixed in a mixture of
methanol, acetone, acetic acid and water (35:35:5:25) for 1
h at 4jC, embedded in paraffin and sectioned at 7 Am. After
dewaxing, tissue sections were hydrated and blocked in 1%
BSA, 0.05% Tween-20 in PBS. Rabbit antibodies and
mouse monoclonal antibodies were incubated simultaneous-
ly in PBS/0.05% Tween-20 overnight at room temperature.Oregon Green-conjugated goat anti-rabbit IgGs (Molecular
Probes) and Texas Red-conjugated goat anti-mouse IgGs
(Molecular Probes) were subsequently used as secondary
antibodies. The tissue was viewed using a Leica fluores-
cence microscope.Results
Morphological examination of clp nerves and comparison
with Oct-6 mutant nerves
Our interest in the clp mouse mutant was initially raised
by the similarities in peripheral nerve phenotypes between
claw paw mice and Oct-6 transcription factor mutant mice
(Bermingham et al., 1996; Henry et al., 1991; Jaegle et al.,
1996). Both mice are characterized by delayed initiation of
myelination of their peripheral nerves. The similarities
between these phenotypes suggested several possible inter-
actions between the Oct-6 and clp genes. For example, it is
possible that the clp gene product is involved in those
signaling pathways that activate Oct-6 or, clp could be a
major regulatory target of Oct-6. Alternatively, clp could act
in a non-redundant pathway parallel to Oct-6. To begin to
answer these questions, we first compared nerve morpho-
logy in both mutant and wild-type mice at several postnatal
stages of development. Previously, nerve morphology in
clp/clp animals has been described only from postnatal day
14 (P14) onwards (Henry et al., 1991). Therefore, we
extended this analysis to include earlier stages of nerve
development. Fig. 1 shows a comparison of representative
transverse sections through the sciatic nerve of animals of
different genetic background at different stages of postnatal
development.
The sorting of prospectively myelinated axonal fibers by
Schwann cells during late fetal development culminates in
the promyelin stage of cell differentiation in which a
Schwann cell has established a one to one relationship with
its axon. These cells will exit the cell cycle, elaborate a basal
lamina and initiate myelination. The majority of myelin-
competent cells transit through this stage during the first
week of postnatal life. This is evident in transverse section
of the wild-type sciatic nerve at birth, in which many
promyelin cells can be observed with some cells already
actively myelinating (Fig. 1A, panel a). By P8, a majority of
cells is actively myelinating and at P16 almost all myelin-
competent cells are in an advanced stage of myelination
(Fig. 1A, panels d and g). In contrast to wild-type, clp/clp
Schwann cells are still at a very immature sorting stage at
birth (Fig. 1, panel b). Most Schwann cells are found at the
periphery of naked axon bundles, with cellular extensions
pioneering into the bundles. This configuration of Schwann
cells and naked axon bundles is typically observed in
embryonic nerves around mouse embryonic day 17 (E17)
(Feltri et al., 2002). To illustrate this developmental stage of
clp/clp Schwann cells more graphically, we traced the
Fig. 1. Abnormal development of peripheral nerves in clp/clp and Oct-6 mutant mice. (A) Shown are representative micrographs of transverse sections of
sciatic nerves from wild-type, clp/clp (claw paw) and Oct-6 mutant (Oct-6hgeo/hgeo) animals at P1 (a, b and c), P8 (d, e and f ) and P16 (g, h and i). At P1,
axonal sorting is well advanced in wild-type nerves, with many axons in a 1:1 relationship with Schwann cells and few in an early myelinating stage (a). In
contrast, axonal sorting in clp/clp nerves is in a very early stage with large groups of unsorted axons (b). Sorting in Oct-6 mutant nerves is well advanced with
most cells in a late sorting and promyelin stage (c). At P8, the majority of myelin-competent Schwann cells in wild-type nerves are actively engaged in
myelination (d), while in clp/clp nerves Schwann cells have now adopted a promyelin configuration (e). At this time, most Oct-6 mutant Schwann cells are
still at the promyelin stage of differentiation (f ). At P16, myelination is well advanced in wild-type nerves (g). In contrast, only a fraction of clp/clp, and Oct-6
mutant, Schwann cells have progressed to the myelinating stage of differentiation with many cells still at the promyelin stage (h and i). Scale bar: (a–c) 1.6
Am; (d– f ) 2.8 Am; (g– i) 5 Am. (B) Axonal sorting is delayed in nerves of clp/clp (claw paw) mice. In this representative micrograph, clp/clp Schwann cells
are just beginning to send out processes in the axon bundles. The outline of sorting Schwann cells is traced with a colored pencil. Each color represents an
individual Schwann cell. Scale bar: 2 Am.
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cytoplasmic extensions of the sorting Schwann cell (Fig.
1B). One week later, these axon bundles are sorted out and a
majority of Schwann cells have acquired a promyelin
configuration (Fig. 1, panel e). Over the next week, many
promyelin cells initiate myelination, such that by P16, a
large number of myelin figures are observed. However, a
substantial number of Schwann cells are still at the promye-
lin stage of cell differentiation, suggesting that this transition
occurs at a lower rate in clp/clp Schwann cells than in wild-
type Schwann cells (Fig. 1, panel h). By P32, the majority of
clp/clp Schwann cells are actively meylinating with only
few cells remaining in the promyelin configuration (data not
shown and Henry et al., 1991). In contrast to clp/clp
Schwann cells, Oct-6 mutant Schwann cells transit through
the sorting stage of development normally, but then stall at
the promyelin stage for several days before initiating myeli-
nation (Fig. 1A, panels c, f and i). Thus, clp/clp Schwann
cells appear strongly inhibited in the sorting stage of nerve
development and to a lesser extent in the promyelinating to
myelinating transition.
One other remarkable difference between clp/clp nerves
and Oct-6 mutant nerves (and wild-type nerves) is the
extensive fasciculation of the former. Division of the endo-
neurium by flattened, perineurial-like cells is already appar-
ent at P8 in clp/clp nerves (Fig. 1A, panel e). As illustratedin Fig. 2A, these cells contain, like perineurial sheath cells,
many caveolae and secrete a basal lamina (arrows and
arrowheads, respectively, in Fig. 2A, panel a). The number
of cell layers that make up the perineurium and the mor-
phology of the perineurial cells appear normal in clp/clp
nerves at P16 and adult (Fig. 2A, panel b, and data not
shown). The hyper-fasciculation phenotype observed in clp/
clp peripheral nerves is reminiscent of that observed in dhh
mutant animals (Parmantier et al., 1999). Therefore, it is
possible that this particular aspect of the claw paw pheno-
type results from a failure to express dhh in the developing
nerve. We therefore examined expression of dhh mRNA in
clp/clp and wild-type nerves at P12 using quantitative PCR
normalized to cyclophilin expression. We found that dhh is
expressed in P12 clp/clp nerves, albeit at reduced levels
(Fig. 2B). It is therefore possible that the extensive subdi-
vision of clp/clp nerves by perineurial sheath cells is a
consequence of reduced dhh expression. It has been hy-
pothesized that the hyperfasciculation of dhh mutant nerves
results from a functionally defective perineurium (Parmant-
ier et al., 1999). A major function of the perineurium is to
prevent the invasion of cells and macromolecules from the
surrounding tissue into the endoneurium (Thomas et al.,
1993). This nerve–tissue barrier function of the perineurium
is compromised in dhh mutant animals as evidenced by the
penetration of dye loaded serum albumin into the endoneu-
Fig. 2. Morphological and functional characterization of the perineurium of claw paw nerves. (A) Perineurial-like cells subdivide the endoneurium of claw paw
nerves (panel a). This electron micrograph shows the typical flattened extensions of perineurial-like cells studded with numerous caveolae (arrows) and the
basal lamina produced by these cells (arrowheads). Schwann cells (Sc) and the nucleus of a perineurial cell (P) are indicated. The number of cellular layers and
the morphology of the perineurial cells appear normal in the developing perineurium of claw paw nerves (panel b). The epineurium is poorly defined at this
stage and later stages. Scale bar: 500 nm. (B) dhh mRNA expression is reduced in claw paw nerves. Expression levels of dhh were estimated using quantitative
RT-PCR during the exponential phase of the reaction and normalized against cyclophilin (cyclo), a housekeeping gene expressed at rather constant levels.
Samples were taken with two-cycle intervals. It is estimated that dhh mRNA levels are 4- to 16-fold lower in claw paw nerves at P12. (C) The nerve– tissue
barrier function of the perineurium is intact in claw paw nerves. Following submersion of dissected sciatic nerve of wild-type (panel a) or claw paw nerve
(panel b) for 1 h in EBA solution, EBA is found associated with the epi- and perineurial sheath of the nerve (arrows). EBA did not penetrate the endoneurium
of wild-type or claw paw nerves (asterisk). However, strong EBA staining is seen within muscle tissue lying next to the nerve (arrowhead).
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integrity of the tissue–nerve barrier in claw paw nerves.
After 1 h exposure to a Evans blue albumin solution ex
vivo, nerves were processed for fluorescence microscopy.
No dye complex had penetrated the endoneurium of wild-
type or claw paw nerves (Fig. 2C, panels a and b, respec-
tively) demonstrating that, in contrast with dhh mutant
nerves, the nerve–tissue barrier in claw paw mice is intact.
Thus, clp/clp nerves resemble dhh mutant nerves in their
extensive subdivision into smaller fascicles by perineurial
sheath cells but have, unlike dhh mutant nerves, a function-
ally intact perineurium.
Activation of Oct-6 expression in clp/clp nerves
As previous work has demonstrated that the transcription
factors Oct-6 and Krox20 are major cell-autonomous regu-
lators of the Schwann cell myelination program, it is
possible that the delayed myelination phenotype in clp/clp
nerves can in part be explained by a failure to activate Oct-6
and subsequently Krox-20, in clp/clp animals (Ghislain et
al., 2002). We therefore examined expression of Oct-6,
Krox-20 and the myelin proteins P-zero and periaxin in
clp/clp animals at P8 and P16 by immunohistochemistry and
compared it with the expression of these proteins in wild-
type and Oct-6 mutant Schwann cells (Fig. 3). At P8, most
clp/clp Schwann cells are, like most Oct-6 mutant cells, at
the promyelin stage of cell differentiation (see Fig. 1) and
will commence myelination in the course of the next 2
weeks. As shown in Fig. 3A, Oct-6 is expressed in Schwann
cells of clp/clp animals at P8. This is in agreement with
previous mRNA expression data (Bermingham et al., 2002).
As reported earlier, Oct-6 is an upstream regulator of Krox-
20 and hence, Oct-6 mutant Schwann cells do not express
Krox-20 (Ghazvini et al., 2002; Ghislain et al., 2002).Despite the expression of Oct-6 in clp/clp Schwann cells,
Krox-20 is not expressed at P8, but eventually is activated in
clp/clp nerves (and Oct-6 mutant nerves) when myelination
proceeds (Ghazvini et al., 2002 and Fig. 3B, panel a). As
expected, P-zero expression is very low in both mutant
mouse strains at P8, as the majority of Schwann cells have
not yet produced compact myelin (Fig. 3A, panels h and i).
However, at P16, clp/clp nerves show strong P-zero immu-
noreactivity in myelin-forming Schwann cells (Fig. 3B,
panel b). Interestingly, the myelin protein periaxin appears
reduced or misexpressed in clp/clp Schwann cells at P8.
This is in contrast to promyelin-arrested Oct-6 mutant
Schwann cells in which periaxin is expressed at near normal
levels (panels j, k and j). However, once clp/clp cells form
compact myelin, high levels of periaxin are observed in
these cells (Fig. 3B, panel c). Thus, in contrast to Oct-6
mutant Schwann cells, periaxin protein does not accumulate
in promyelin-arrested clp/clp Schwann cells suggesting that
the clp mutation affects activation of periaxin expression or
subcellular localization and/or processing.
To distinguish between these possibilities, we further
examined periaxin expression at late fetal stages of deve-
lopment in clp/clp and wild-type animals. Periaxin is first
expressed in the nuclei of embryonic Schwann cells at E14.
By E17, periaxin expression shifts to the cell membrane and
by E18, periaxin is no longer found in the nucleus (Sherman
and Brophy, 2000). We examined periaxin expression in
clp/clp Schwann cells of embryonic nerves at E17, the stage
at which claw paw animals can first be recognized. No
periaxin is detected in clp/clp nerves at this stage (Fig. 4A,
panel d). In contrast, wild-type Schwann cells express
periaxin in the nucleus and/or in the cytoplasm (Fig. 4A,
panel c). Thus, the clp mutation affects onset of periaxin
expression at this embryonic stage and subsequently, also
the subcellular localization of the periaxin protein.
Fig. 3. Developmental expression of Oct-6, Krox-20, P-zero and periaxin in clp/clp and Oct-6mutant nerves. (A) Transverse sections of sciatic nerves of clp/clp
(claw paw), Oct-6 mutant (Oct-6DSCE/DSCE) and control (wild-type) mice at P8 were stained for Oct-6 (a–c), Krox-20 (d–e), P-zero (g– i) and periaxin (j – l). In
the control nerve, myelinating Schwann cells express Oct-6, Krox-20 and the myelin proteins P-zero and periaxin (a, d, g and j). At P8, most clp/clp Schwann
cells have adopted a promyelin configuration and express Oct-6 (b) but not the myelination-associated transcription factor Krox-20 (f ). Some cells express
appreciable levels of P-zero. These cells are probably in an advanced promyelin stage as there is no evidence of compact myelin yet at this stage (h). Very low
cytoplasmic periaxin expression is observed in many, but not all, cells (k). Few cells exhibit high level of periaxin expression. No nuclear periaxin staining is
observed at this stage. Like clp/clp Schwann cells, Oct-6 mutant Schwann cells do not express Oct-6 or Krox-20 at this stage (c and e). The few cells that have
initiated myelin formation are strongly positive for P-zero (i). In strong contrast to clp/clp Schwann cells (k), Oct-6 mutant cells express already high levels of
periaxin at this stage (l). Magnification 40. (B) Myelin formation is evident in clp/clp nerves at P16. An appreciable number of Schwann cells have initiated
myelination and express Krox-20 (a). High levels of P-zero and periaxin are present in Schwann cells that have formed compact myelin (b and c).
Magnification 40.
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onset of expression. Oct-6 protein normally starts to accu-
mulate in the nuclei of immature Schwann cells of the
sciatic nerve at late fetal stages and reaches maximum levels
in promyelin cells during the first postnatal week of deve-
lopment. As clp/clp Schwann cells at P1 morphologically
resemble Schwann cells in E16–E17 wild-type embryonic
nerves, we examined Oct-6 expression in P1 clp/clp nerves.
At this stage, we found that clp/clp Schwann cells already
express appreciable levels of Oct-6 (Fig. 4B, panel b),
demonstrating that the clp gene product does not affect
activation of Oct-6 expression. In contrast to wild-type Oct-
6-positive Schwann cells, Oct-6-positive clp/clp Schwann
cells do not express appreciable levels of P-zero protein
(Fig. 4B, panels c and d).Taken together, these data demonstrate that the clp
mutation affects nerve maturation through a pathway that
includes activation of periaxin, but not Oct-6, and thus
strongly suggest that during Schwann cell differentiation,
periaxin and Oct-6 are regulated through distinct signaling
pathways.
Nerve conduction velocities of clp nerves are reduced
The delayed maturation of peripheral nerves in clp/clp
animals results in reduced internodal lengths for all diameter
classes and thus, in the absence of axonal loss, increased
Schwann cell numbers. In addition, myelin thickness is
reduced in some, but not all, clp/clp animals and no decrease
in mean axon diameter was reported (Henry et al., 1991;
Fig. 5. Nerve conduction velocities are reduced in clp/clp nerves. (A)
Representative recordings of compound action potentials of the tail nerve of
wild-type (wt) and clp/clp (claw paw) animals. Arrows indicate the
stimulation artefact. (B) Mean conduction velocity for wild-type (wt) and
clp/clp (claw paw) nerves. The number (n) of animals from which
recordings were obtained in each group is indicated. The error bar
represents standard deviation. The difference in mean NCV between clp/clp
and wild-type animals is significant (P < 0.00001, Student’s t test).
Fig. 4. Expression of periaxin and Oct-6 in clp/clp Schwann cells. (A) Embryonic sciatic nerve is visualized by expression of the neurofilament medium chain
in the axonal fibers (Nfm; a and b). Embryonic Schwann cells within the nerve express periaxin in their cytoplasm or nucleus (c). In contrast, no periaxin
expression is observed in nerves of claw paw embryos at this stage of development (d). (B) Oct-6 is expressed in all Schwann cells in newborn wild-type sciatic
nerves (a). Also, Schwann cells in sciatic nerves of clp/clp animals express Oct-6 (b). Other than wild-type Schwann cells, clp/clp Schwann cells uniformly
express high levels of Oct-6. In wild-type nerves, many Schwann cells are at the promyelin configuration and some have initiated myelination and thus express
high levels of P-zero (c). In contrast, clp/clp Schwann cells appear at an early sorting stage at P1 (see Fig. 1) and do not express detectable levels of P-zero
protein (d).
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every axonal diameter class in clp/clp animals is approxi-
mately half of that of wild-type animals. Intuitively, and on
theoretical considerations, it is to be expected that propaga-
tion of action potentials will be slowed when the mean
internodal length drops well below its optimum (Brill et al.,
1977; Goldman and Albus, 1968; Rushton, 1951). To assess
nerve conduction velocity (NCV) in clp and wild-type
animals, we measured compound action potentials (CAP)
of the tail nerve (Fig. 5A). The mean NCV in wild-type and
heterozygous mice was 35.3 m/s (SD 1.8). In contrast, the
mean NCV in clp/clp mice was 23.9 m/s (SD 2.2), a
reduction of 35% (Fig. 5B). A similarly reduced conduction
velocity was observed for motor nerves within the sciatic
nerve of clp/clp animals as compared to wild type (data not
shown). Reduced NCV in the tail nerve of claw paw mice
shows little variance, and this variance does not correlate
with age or severity of the behavioral phenotype. Thus, it is
possible that the reduction in NCV in clp/clp animals can be
accounted for, at least in part, by the reduction in mean
internodal length.
Response to nerve injury
Although the claw paw phenotype has been described as
a developmental abnormality, it is not clear from these
observations whether the phenotype results from an intrinsic
defect in one or more components of the developing nerve
or through defects in other organs of the developing fetus.
Studying the damage response of the nerve in the adult
animal allows examination of Schwann cell–axon interac-
A. Darbas et al. / Developmental Biology 272 (2004) 470–482 477tions that are largely a reiteration of developmental events
(Scherer and Salzer, 1996). Following nerve transection,
axons and myelin in the distal nerve segment disintegrate in
a process called Wallerian degeneration. Schwann cells
revert back to an immature pre-myelinating phenotype,
proliferate and participate with macrophages in the removal
of myelin and axonal debris. These reactive Schwann cells
create an environment that stimulates axonal regeneration of
the transected neurones. Upon restoration of axonal contact,
Schwann cells differentiate into myelin or non-myelin
forming cells (Scherer and Salzer, 1996). Therefore, if the
clp defect resides within the nerve tissue, it is likely that at
least part of the defect will be recapitulated during nerve
regeneration following nerve axotomy in an adult animal.
On the other hand, if the clp defect is strictly developmental
and not intrinsic to the nerve tissue, it is expected that
regeneration will be relatively normal.
To examine the effect of the clp mutation on Schwann
cell–axon interaction during regeneration, the sciatic nerve
of adult clp/clp and wild-type mice were crushed and
studied morphologically 4 weeks later (Fig. 6). The nerves
were sectioned at two levels distal to the injury, 3 and 6 mm,
respectively, representing two successive stages of regener-
ation. In wild-type animals, regeneration is well advanced,
with only few remnants of myelin remaining (arrows in Fig.
6A, panel b) and most axons associated with compact
myelin. Regeneration of clp/clp nerves differs significantly
from wild-type nerves in some aspects. First, most large-
caliber axons are ensheathed by a single Schwann cell, but
only a few of these are associated with a thin compact
myelin sheath (Fig. 6A, panels e and f). Second, supernu-
merary Schwann cells surround large axon–Schwann cell
units and are associated with numerous thin axons (Fig. 6B).
These structures are enclosed by the original basal laminaFig. 6. Abnormal response to nerve injury in clp/clp mice. (A) Light micrographs o
paw) animals 4 weeks after nerve crush. The myelin sheath in clp/clp nerves is th
nerves, regeneration is well advanced, both at 3 and 6 mm distal of the nerve crush
regenerated axons are myelinated. Regeneration in clp/clp nerves is delayed with
mm distal to the lesion, corresponding to a later time point in regeneration (f ). Exc
cells enclosing a group of regenerating fibers is indicated with arrows (e). Scale b
supernumerary Schwann cells are associated with regenerating axons. In addition
are observed within the regenerating unit that is enclosed by one basal lamina (a(arrows in Fig. 6B), indicating excessive sprouting of the
regenerating axon. Third, excessive fasciculation results in a
further subdivision of the clp nerve (Fig. 6A, panels e and f).
Thus, while clp axons do grow back into the distal nerve
stump, regeneration is clearly disturbed. Some of these
regeneration abnormalities, such as delayed myelination
and hyper-fasciculation, are also observed during develop-
ment suggesting that the clp defects are caused by a nerve
intrinsic defect in one or more components within the
developing or regenerating nerve.
Nerve grafting
To distinguish between a Schwann cell and neuronal
defect in the regeneration of clp/clp nerves, we performed
nerve grafting experiments. Nerve transplantation experi-
ments create a situation in which Schwann cells, genetically
distinct from the host, differentiate in association with host-
derived neurons (Aguayo et al., 1977; de Waegh and Brady,
1991; Scaravilli and Jacobs, 1981). We performed nerve
transplantation operations in which a wild-type host was
engrafted with a segment of a wild-type (wt:wt) or clp/clp
(clp:wt) sciatic nerve segment. Also, the converse set of
transplantations was performed in which a clp/clp host was
engrafted with a wild-type (wt:clp) or clp/clp (clp:clp)
sciatic nerve segment. The poorly developed epineurium
of clp/clp nerves as compared to that of wild-type nerves
made the grafting of the segments particularly demanding
on the technical level. Four weeks after the operation, the
transplanted nerves were isolated and examined microscop-
ically. Each nerve was serially sectioned and examined at
250-Am intervals. Representative sections from the middle
of the graft and proximal and distal to the anastomosis site
are shown in Fig. 7. In the wt:wt transplantation, regenerat-f cross sections of sciatic nerves of young adult wild-type and clp/clp (claw
inner than in wild-type nerves, as described earlier (a and d). In wild-type
(b and c), with only little myelin debris remaining (arrows in panel b). All
only few regenerated axons myelinated. This is even more pronounced at 6
essive fasciculation is evident in the regenerating nerve. A layer of epineural
ar: 10 Am. (B) In this electron micrograph of a regenerating clp/clp nerve,
to the large central axon, excessive numbers of axon sprouts (red asterisks)
rrows). The cross section is through three Schwann cells. Scale bar: 2 Am.
Fig. 7. Nerve grafting experiments reveal Schwann cell and neuronal expression of the clp defect. Light micrographs of semi-thin cross sections of sciatic nerve
at three different levels of the engrafted nerve 4 weeks after the operation. The position of the sections relative to the engrafted segment is schematically
depicted in the diagram above the micrographs. At the level of the engrafted segment and distal to this segment, three different configurations are expected:
regenerated axons myelinated by graft-derived Schwann cells (blue in diagram); Schwann cell tubes (blue) that do not get re-innervated by host neurones and
host axons that do not enter the nerve graft and are associated with host-derived Schwann cells (gray in diagram) that migrate with the regenerating axons.
Donor and recipient genotypes (donor/recipient) are listed to the left. Non-innervated Schwann cell tubes with myelin debris are indicated with arrows in panel
b. Thinly myelinated axons that have re-innervated the distal nerve segment of the wild-type host are indicated in panel f with arrows. Arrows in panel h also
point to regenerating wild-type axons that are myelinated by clp/clp Schwann cells. For further details, see text. Scale bar: 10 Am.
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distal nerve stump. Wild-type Schwann cells in the graft and
distal nerve stump have formed compact myelin around
regenerated axons (Fig. 7, panels b and c). Schwann cell
tubes (reactive Schwann cells within their basal lamina:
bands of Bunger) that were not re-innervated still containsome myelin debris (arrows in panel b). In the clp:wt
transplantation, wild-type axons do regenerate through a
clp/clp nerve graft into the distal nerve stump (Fig. 7, panels
e and f ). Moreover, in contrast to wild-type Schwann cells,
clp/clp Schwann cells have only myelinated the larger axons
in the graft and many axons are still in an early ensheathing
A. Darbas et al. / Developmental Biology 272 (2004) 470–482 479or promyelin configuration (panel e). Smaller axons that
have navigated through the graft and have entered the distal
nerve stump are normally myelinated (arrows in panel f ).
These observations suggest that at least part of the delayed
myelination phenotype in clp/clp animals is Schwann cell
autonomous.
Transplantations of wild-type nerve segments into clp/
clp hosts were less successful as ligations to the distal
nerve stump did not hold. Nevertheless, clp/clp axons did
enter the wild-type nerve graft and were myelinated by the
wild-type Schwann cells within the graft (Fig. 7, panel h).
Also smaller-caliber claw paw axons were myelinated
(arrows in panel h). Distal to the second anastomosis site,
regrowing axons did not enter the distal nerve stump, but
were found associated with a large blood vessel (not
shown). Most likely, graft-derived perineural cells and
Schwann cells accompany these axons (panel i). Notwith-
standing, these data suggest that wild-type Schwann cells
receive appropriate signals from clp/clp neurones to mye-
linate them. Finally, the clp:clp transplantations show that
clp/clp axons do grow through the grafted segment into the
distal nerve stump. Consistent with the results in the clp/clp
nerve crush experiment (Fig. 6), regenerating clp/clp axons
are associated with supernumerary Schwann cells and only
few axons are thinly myelinated (Fig. 7, panels k and l).
We also observe a further increase in the extent of
fasciculation. This increased fasciculation was less pro-
nounced in the clp:wt and in wt:clp transplantations.
Therefore, this specific aspect of the claw paw phenotype
arises mainly from interaction of clp/clp axons with the clp/
clp endoneurium. This is also true for the delayed myeli-
nation phenotype, as it is much more severe in the clp:clp
transplantation than in the clp:wt and wt:clp transplanta-
tions. Thus, while the former two grafting experiments
(wt:clp and clp:wt) suggest a Schwann cell autonomous
effect of the clp mutation on myelination, the nerve crush
and clp:clp transplantation suggest that there is also an
important Schwann cell non-autonomous, most likely neu-
ronal, aspect to the clp mutation.Discussion
We have studied the cellular and molecular basis of the
congenital limb abnormality manifested by claw paw mutant
mice. Our findings demonstrate that the clp mutation affects
both the axonal and endoneural/Schwann cell compartment,
resulting in axonal sorting and myelination defects. At the
molecular level, clp affects a signaling pathway that is
parallel and non-redundant to the Oct-6-dependent pathway,
suggesting that axonal signals that drive Schwann cell
differentiation and myelination are transduced through mul-
tiple parallel pathways. These findings suggest several
possible roles for the clp gene and, additionally, define a
set of requirements for clp candidate genes, to be identified
in the ongoing positional cloning effort.What process in nerve development is affected by the clp
mutation?
The development of peripheral nerve tissue can be
conveniently thought of as an ordered series of cellular
transitions that result from several complex interactions
between Schwann cells, axons, mesenchymal cells and
extracellular components (Jessen and Mirsky, 1999; Web-
ster, 1993). The first transition occurs when migrating neural
crest cells associate with outgrowing axon bundles and
acquire Schwann cell precursor characteristics (Jessen and
Mirsky, 1991; Jessen et al., 1994). These cells proliferate,
migrate with the growing axons and, in a second transition,
differentiate into immature Schwann cells that invade the
axon bundles and start the process of radial sorting of nerve
fibers. This process culminates in larger axons singled out
by individual Schwann cells (promyelin stage) which, in a
third transition, will go on to myelinate their axon and
multiple smaller axons associated with Schwann cells to
form the so-called Remak fibers of non-myelinated axons.
During this last phase, immature Schwann cells exit the cell
cycle and elaborate an extracellular matrix. The peri- and
epineural layers that surround and protect the nerve differ-
entiate from the surrounding mesenchyme in a process that
requires Schwann cell-derived desert hedgehog signaling
(Bunge et al., 1989; Du Plessis et al., 1996; Parmantier et al.,
1999).
The major defects in the developing and adult peripheral
nerves of claw paw mutant mice were originally described as
a general delay of myelination initiation and the persistence
of promyelin fibers in adult animals (Henry et al., 1991). On
the basis of these morphological observations, Henry et al.
hypothesized that the clp defect affects the complex signal-
ing between axon, Schwann cell and extracellular compo-
nents that control the transition of promyelin Schwann cells
into myelinating cells. Molecular studies have shown that
this transition is mediated by the activity of the transcription
factors Oct-6 and Krox-20 acting consecutively in the
Schwann cells (Ghislain et al., 2002). Our finding that clp
does not affect activation of Oct-6 expression but that Krox-
20 activation is delayed suggests that clp acts either down-
stream of Oct-6 or in a second non-redundant pathway.
Several observations presented here argue in favor of the
second possibility. Morphological examination of nerves of
newborn claw paw animals revealed that Schwann cells are
still at an early sorting stage of development while wild-type
and Oct-6 mutant Schwann cells are at the end of the sorting
stage. This early sorting stage observed in P1 clp/clp nerves
would be appropriate for embryonic nerves in E16–E18
wild-type embryos. Sorting and ensheathment of axons by
Schwann cells critically depends on rearrangements of the
Schwann cell cytoskeleton. Deletion of the h1 integrin or
the laminin g1 gene in Schwann cells results in impaired
sorting of axon bundles, suggesting that these rearrange-
ments are mediated through interactions between the extra-
cellular matrix laminins and their integrin receptors (Chen
A. Darbas et al. / Developmental Biology 272 (2004) 470–482480and Strickland, 2003; Feltri et al., 2002; Saito et al., 2003).
The similarity in ultrastructural abnormalities observed in
newborn clp/clp, h1 integrin and laminin g1 mutant nerves,
suggests that clp acts in these pathways. In contrast to
laminin g1 null Schwann cells, clp/clp Schwann cells are
not permanently blocked at the sorting stage. It is therefore
likely that a clp redundant function exists or that the clp
allele is a hypomorph.
In addition, clp/clp nerves exhibit hyperfasciculation, a
phenotype resembling that observed in dhh mutant mice,
suggesting the possibility that this specific aspect of the claw
paw mutant phenotype results from downregulation of dhh
expression. In agreement with this suggestion, we found that
dhhmRNA is expressed at reduced levels in clp/clp nerves (at
P12). However, in contrast to dhhmutant animals, the nerve–
tissue barrier function of the perineurium in claw paw animals
is not affected (Fig. 2). As the biological effects of hedgehog
proteins are known to be dose-dependent, it is tempting to
speculate that the differences in phenotype between dhh
mutant and clp/clp nerves reflect differences in dhh expression
levels in the developing nerves of these two mutant animals.
Nuclear periaxin expression in embryonic Schwann cells,
and the later accumulation of periaxin in promyelin cells at
P8, is not observed in claw paw nerves at these stages (Figs.
2 and 3), although periaxin does eventually accumulate in
Oct-6 and Krox-20 expressing myelinating clp/clp Schwann
cells (Fig. 2). It has recently been suggested that a dual
mechanism of periaxin regulation exists in which Krox-20
amplifies an earlier Krox-20 independent activation of the
periaxin gene (Parkinson et al., 2003). Our results suggest
further that the early Krox-20 independent activation of
periaxin is regulated through a clp-dependent pathway.
Alternatively, it is possible that clp Schwann cells at E17
represent an earlier differentiation stage at which periaxin is
not expressed yet (they will have to be very early Schwann
cell precursors, as E14 Schwann cell precursors express
periaxin in their nuclei, (Sherman and Brophy, 2000). It is
unlikely that the absence of detectable levels of periaxin in
clp Schwann cells contributes significantly to the peripheral
nerve phenotype in claw paw mice, as peripheral nerve
development is morphologically normal in periaxin null
mice (Gillespie et al., 2000).
Thus, in contrast to what has been suggested earlier, the
clp mutation affects nerve development at a stage well
before the promyelin-myelinating transition. The particular
defects suggest that clp is involved in axon–Schwann cell
interactions that drive the invasion and sorting of immature
Schwann cells and the subsequent elaboration of a basal
lamina and myelination initiation.
On the nature of the claw paw mutation
In the absence of knowledge about the mutation under-
lying the claw paw phenotype, we do not know what
mechanism could account for the peripheral nerve develop-
mental defect and the behavioral defect in claw pawanimals. However, on the basis of the observed develop-
mental defects, the recessive nature of the clp mutation and
in particular the results of regeneration and nerve transplan-
tation experiments, we can speculate on possible scenarios.
Although the morphological abnormalities observed in the
nerve of claw paw animals suggest that the clp mutation
affects primarily Schwann cells, the transplantation and
nerve regeneration experiments suggest that clp function
might also be required in the neurone and possibly the
endoneurial fibroblasts. It is therefore likely that the clp
gene product is expressed and functioning in both Schwann
cells and neurones and that the clp mutation is not a gain of
function mutation. These suggestions are compatible with
clp functioning in, or regulating, homo- or heterophilic
interactions between axons and Schwann cells. For exam-
ple, it is possible that the claw paw protein is involved in
bringing adhesion molecules to the cell surface or that claw
paw itself is a cell surface protein directly involved in cell–
cell interactions. Alternatively, it is possible that the clp
mutation is a regulatory mutation affecting expression of
genes involved in the abovementioned interactions. These
impaired axon Schwann cell interactions at an early stage
could have repercussions for nerve activity during fetal
stages and affect the normal spontaneous movement of the
fetus, important for proper posture development.
In summary, we have provided evidence that the mouse
clp mutation affects the Schwann cell compartment and
possibly the neuronal compartment of the regenerating and,
by extension, the developing nerve, suggesting that the clp
gene is expressed in Schwann cells and neurones and is
involved in direct axon–Schwann cell interactions. Further-
more, the clp mutation affects early activation of periaxin
expression and Krox20 expression in Schwann cells, but
does not affect the signaling pathway that activates Oct-6
expression, suggesting that axonal signals that initiate
myelination are transduced through multiple parallel, non-
redundant pathways.Acknowledgments
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